Journal of Biomolecular Screening

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1087057106296498v1
12/2/229    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sui, Y.
Right arrow Articles by Wu, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sui, Y.
Right arrow Articles by Wu, Z.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
This version was published on March 1, 2007
Journal of Biomolecular Screening, Vol. 12, No. 2, 229-234 (2007)
DOI: 10.1177/1087057106296498
© 2007 Society for Biomolecular Sciences

Alternative Statistical Parameter for High-Throughput Screening Assay Quality Assessment

Yunxia Sui

Department of Community Health, Brown University, Providence, RI

Zhijin Wu

Center for Statistical Sciences and Department of Community Health, Brown University, Providence, RI

High-throughput screening is an essential process in drug discovery. The ability to identify true active compounds depends on the high quality of assays and proper analysis of data. The Z factor, presented by Zhang et al. in 1999, provides an easy and useful summary of assay quality and has been a widely accepted standard. However, as data analysis has undergone much improvement recently, the assessment of assay quality has not evolved in parallel. In this article, the authors study the implications of Z factor values under different conditions and link the Z factor with the power of discovering true active compounds. They discuss the different interpretations of Z factor depending on error distributions and advocate direct analysis of power as assay quality assessment. They also propose that in estimating assay quality parameters, adjustments in data analysis should be taken into account. Studying the power of identifying true "hits" gives a more direct interpretation of assay quality and may provide guidance in assay optimization on some occasions.

Key Words: high-throughput screening • statistics • Z factor • power • assay validation


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J Biomol ScreenHome page
X. D. Zhang, A. S. Espeseth, E. N. Johnson, J. Chin, A. Gates, L. J. Mitnaul, S. D. Marine, J. Tian, E. M. Stec, P. Kunapuli, et al.
Integrating Experimental and Analytic Approaches to Improve Data Quality in Genome-wide RNAi Screens
J Biomol Screen, June 1, 2008; 13(5): 378 - 389.
[Abstract] [PDF]


Home page
J Biomol ScreenHome page
X. D. Zhang
Novel Analytic Criteria and Effective Plate Designs for Quality Control in Genome-Scale RNAi Screens
J Biomol Screen, June 1, 2008; 13(5): 363 - 377.
[Abstract] [PDF]